Brain areas lipidomics in female transgenic mouse model of Alzheimer's disease

Abstract Lipids are the major component of the brain with important structural and functional properties. Lipid disruption could play a relevant role in Alzheimer’s disease (AD). Some brain lipidomic studies showed significant differences compared to controls, but few studies have focused on differe...

Full description

Bibliographic Details
Main Authors: Laura Ferré-González, Ángel Balaguer, Marta Roca, Artemis Ftara, Ana Lloret, Consuelo Cháfer-Pericás
Format: Article
Language:English
Published: Nature Portfolio 2024-01-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-024-51463-3
_version_ 1797276543545769984
author Laura Ferré-González
Ángel Balaguer
Marta Roca
Artemis Ftara
Ana Lloret
Consuelo Cháfer-Pericás
author_facet Laura Ferré-González
Ángel Balaguer
Marta Roca
Artemis Ftara
Ana Lloret
Consuelo Cháfer-Pericás
author_sort Laura Ferré-González
collection DOAJ
description Abstract Lipids are the major component of the brain with important structural and functional properties. Lipid disruption could play a relevant role in Alzheimer’s disease (AD). Some brain lipidomic studies showed significant differences compared to controls, but few studies have focused on different brain areas related to AD. Furthermore, AD is more prevalent in females, but there is a lack of studies focusing on this sex. This work aims to perform a lipidomic study in selected brain areas (cerebellum, amygdala, hippocampus, entire cortex) from wild-type (WT, n = 10) and APPswe/PS1dE9 transgenic (TG, n = 10) female mice of 5 months of age, as a model of early AD, to identify alterations in lipid composition. A lipidomic mass spectrometry-based method was optimized and applied to brain tissue. As result, some lipids showed statistically significant differences between mice groups in cerebellum (n = 68), amygdala (n = 49), hippocampus (n = 48), and the cortex (n = 22). In addition, some lipids (n = 15) from the glycerolipid, phospholipid, and sphingolipid families were statistically significant in several brain areas simultaneously between WT and TG. A selection of lipid variables was made to develop a multivariate approach to assess their discriminant potential, showing high diagnostic indexes, especially in cerebellum and amygdala (sensitivity 70–100%, sensibility 80–100%).
first_indexed 2024-03-07T15:29:40Z
format Article
id doaj.art-5ffdce1e466f45598095dea9258088c2
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-03-07T15:29:40Z
publishDate 2024-01-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-5ffdce1e466f45598095dea9258088c22024-03-05T16:28:49ZengNature PortfolioScientific Reports2045-23222024-01-0114111110.1038/s41598-024-51463-3Brain areas lipidomics in female transgenic mouse model of Alzheimer's diseaseLaura Ferré-González0Ángel Balaguer1Marta Roca2Artemis Ftara3Ana Lloret4Consuelo Cháfer-Pericás5Alzheimer’s Disease Research Group, Health Research Institute La FeFaculty of Mathematics, University of ValenciaAnalytical Unit, Health Research Institute La FeUniversity of ValenciaDepartment of Physiology, Faculty of Medicine, University of Valencia, Health Research Institute INCLIVAAlzheimer’s Disease Research Group, Health Research Institute La FeAbstract Lipids are the major component of the brain with important structural and functional properties. Lipid disruption could play a relevant role in Alzheimer’s disease (AD). Some brain lipidomic studies showed significant differences compared to controls, but few studies have focused on different brain areas related to AD. Furthermore, AD is more prevalent in females, but there is a lack of studies focusing on this sex. This work aims to perform a lipidomic study in selected brain areas (cerebellum, amygdala, hippocampus, entire cortex) from wild-type (WT, n = 10) and APPswe/PS1dE9 transgenic (TG, n = 10) female mice of 5 months of age, as a model of early AD, to identify alterations in lipid composition. A lipidomic mass spectrometry-based method was optimized and applied to brain tissue. As result, some lipids showed statistically significant differences between mice groups in cerebellum (n = 68), amygdala (n = 49), hippocampus (n = 48), and the cortex (n = 22). In addition, some lipids (n = 15) from the glycerolipid, phospholipid, and sphingolipid families were statistically significant in several brain areas simultaneously between WT and TG. A selection of lipid variables was made to develop a multivariate approach to assess their discriminant potential, showing high diagnostic indexes, especially in cerebellum and amygdala (sensitivity 70–100%, sensibility 80–100%).https://doi.org/10.1038/s41598-024-51463-3
spellingShingle Laura Ferré-González
Ángel Balaguer
Marta Roca
Artemis Ftara
Ana Lloret
Consuelo Cháfer-Pericás
Brain areas lipidomics in female transgenic mouse model of Alzheimer's disease
Scientific Reports
title Brain areas lipidomics in female transgenic mouse model of Alzheimer's disease
title_full Brain areas lipidomics in female transgenic mouse model of Alzheimer's disease
title_fullStr Brain areas lipidomics in female transgenic mouse model of Alzheimer's disease
title_full_unstemmed Brain areas lipidomics in female transgenic mouse model of Alzheimer's disease
title_short Brain areas lipidomics in female transgenic mouse model of Alzheimer's disease
title_sort brain areas lipidomics in female transgenic mouse model of alzheimer s disease
url https://doi.org/10.1038/s41598-024-51463-3
work_keys_str_mv AT lauraferregonzalez brainareaslipidomicsinfemaletransgenicmousemodelofalzheimersdisease
AT angelbalaguer brainareaslipidomicsinfemaletransgenicmousemodelofalzheimersdisease
AT martaroca brainareaslipidomicsinfemaletransgenicmousemodelofalzheimersdisease
AT artemisftara brainareaslipidomicsinfemaletransgenicmousemodelofalzheimersdisease
AT analloret brainareaslipidomicsinfemaletransgenicmousemodelofalzheimersdisease
AT consuelochaferpericas brainareaslipidomicsinfemaletransgenicmousemodelofalzheimersdisease